- Home
- PODC vs ALGS Comparison
PODC vs ALGS Comparison
Compare PODC & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$10.00
Company Overview
Basic Information| Metric | PODC | ALGS |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.5M | 57.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PODC | ALGS |
|---|---|---|
| Price | $2.16 | $10.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 76.4K | ★ 76.5K |
| Earning Date | 11-11-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,957,000.00 | $2,646,000.00 |
| Revenue This Year | $17.39 | N/A |
| Revenue Next Year | $19.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.01 | N/A |
| 52 Week Low | $1.28 | $3.76 |
| 52 Week High | $2.94 | $46.80 |
Technical Indicators
Market Signals| Indicator | PODC | ALGS |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 64.25 |
| Support Level | $1.91 | $9.10 |
| Resistance Level | $2.40 | $10.45 |
| Average True Range (ATR) | 0.24 | 0.65 |
| MACD | -0.05 | 0.23 |
| Stochastic Oscillator | 27.91 | 91.74 |
Price Performance
Historical Comparison PODC
ALGS
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.